HeartCore Enterprises sold its subsidiary HeartCore Japan for ¥1.8 billion, shifting focus to IPO consulting services.
Quiver AI Summary
HeartCore Enterprises, Inc., a Tokyo-based IPO consulting firm, has announced the sale of its subsidiary HeartCore Co. Ltd. to Volaris Group for approximately ¥1.8 billion yen (around USD $12 million). This decision reflects a strategic shift in response to the evolving landscape of generative AI, prompting HeartCore to divest its software business and focus on its Go IPO consulting services, which yield higher profitability. The transaction will also facilitate a one-time distribution of $0.13 per share to its shareholders, with the record and payment dates set for November 10 and 17, 2025, respectively. CEO Sumitaka Kanno highlighted the potential growth in the Go IPO sector, especially with new market capitalization requirements, and expressed confidence in the company's ability to drive long-term shareholder value.
Potential Positives
- HeartCore successfully sold its subsidiary HeartCore Japan for approximately ¥1.8 billion yen (USD $12 million), allowing the company to unlock cash resources and focus on its Go IPO consulting business.
- The company is initiating a one-time distribution payment of $0.13 per share to shareholders, representing about 17.2% of the stock price as of October 29, 2025, which provides immediate financial benefits to its investors.
- HeartCore's Go IPO consulting business is positioned to benefit from recent regulatory changes, creating significant growth opportunities and potential long-term value for shareholders.
- Building a strong pipeline in Korea and executing an organic growth strategy suggests that HeartCore is taking proactive steps to expand its market presence and drive future success.
Potential Negatives
- The sale of HeartCore Japan suggests a significant shift in the company's business strategy, indicating potential weaknesses in its software operations.
- The divestiture of the software business will result in a reduction of near-term revenue, which may concern investors relying on consistent income.
- The company’s reliance on the success of its Go IPO consulting business could pose risks, particularly if the market conditions or demand change adversely, as indicated by the need to adapt to regulatory changes in the Tokyo Stock Exchange.
FAQ
Why did HeartCore sell its subsidiary HeartCore Japan?
HeartCore sold HeartCore Japan to focus on its profitable Go IPO consulting business amid the shift towards generative AI in software.
What is the sales price for HeartCore Japan?
The all-cash deal for HeartCore Japan was approximately ¥1.8 billion yen, or about USD $12 million.
When will shareholders receive the distribution payment?
The one-time distribution payment of $0.13 per share will be paid on November 17, 2025, with a record date of November 10, 2025.
What new strategy is HeartCore adopting?
HeartCore plans to transition to a financial consulting firm, focusing exclusively on its Go IPO business for sustainable long-term value.
How does the Tokyo Stock Exchange's change affect HeartCore?
The increased market cap requirement for Growth Market companies accelerates the opportunity for HeartCore's Go IPO services, potentially enhancing their growth trajectory.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$HTCR Insider Trading Activity
$HTCR insiders have traded $HTCR stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $HTCR stock by insiders over the last 6 months:
- DAISHIN YASUI has made 0 purchases and 4 sales selling 120,869 shares for an estimated $81,570.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HTCR Hedge Fund Activity
We have seen 2 institutional investors add shares of $HTCR stock to their portfolio, and 11 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. removed 132,274 shares (-84.2%) from their portfolio in Q2 2025, for an estimated $64,801
- CREATIVEONE WEALTH, LLC removed 121,257 shares (-65.6%) from their portfolio in Q2 2025, for an estimated $59,403
- RENAISSANCE TECHNOLOGIES LLC removed 76,400 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $37,428
- CITADEL ADVISORS LLC removed 63,133 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $30,928
- UBS GROUP AG added 31,866 shares (+inf%) to their portfolio in Q2 2025, for an estimated $15,611
- CORSAIR CAPITAL MANAGEMENT, L.P. removed 29,186 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $14,298
- PROSPERITY FINANCIAL GROUP, INC. removed 25,000 shares (-53.8%) from their portfolio in Q2 2025, for an estimated $12,247
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
NEW YORK and TOKYO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”) , an IPO consulting services company based in Tokyo, announced today it has sold its subsidiary HeartCore Co. Ltd. (“HeartCore Japan”) to Volaris Group UK Holdco LTD (“Volaris Group”) in an all-cash deal for approximately ¥1.8 billion yen (equivalent to approximately USD $12 million, based on the October 24, 2025 Federal Reserve conversion rate of ¥152.82 = USD $1). HeartCore Japan is engaged in the business of developing and sales of comprehensive software.
“The rapid evolution of generative AI has fundamentally reshaped the competitive landscape for traditional software businesses like ours,” said HeartCore CEO Sumitaka Kanno. “Generative AI agents are now capable of matching and even outperforming many conventional software offerings and businesses. With this apparent change in the industry, we have spent the past several months carefully evaluating the best path forward to continue delivering value to our shareholders. Rather than expending resources to compete against this industry-wide shift, HeartCore’s management and board have made the strategic decision to sell our software business assets in Japan at what we believe to be the highest achievable value at this stage and to concentrate our efforts on our robust Go IPO consulting business.
“While this transaction does not include our subsidiary Sigmaways, we will continue to assess all strategic alternatives to divest this portion of the business as soon as possible. We believe that the planned exit from all software business activities will allow us to focus exclusively on our highly profitable Go IPO business, transitioning from a software and consulting business model to a financial consulting firm. While the divestiture of our software business will reduce near-term revenue, our Go IPO pipeline remains strong. Looking ahead to 2026, we have multiple Go IPO clients scheduled to begin trading, and we believe the highly profitable nature of this business will enable us to drive sustainable, long-term value for our shareholders.”
Use of Proceeds – Distribution to Shareholders
As
previously announced
, the Company has authorized a one-time distribution payment to its shareholders in the amount of $0.13 per share of common stock. We expect to use a portion of the proceeds from the HeartCore Japan sale to pay the distribution. The record date for holders of the common stock to participate in the distribution is November 10, 2025, and the payment date will be November 17, 2025. The one-time distribution payment of $0.13 per share represents approximately 17.2% of the Company’s stock price as of market close on October 29, 2025.
Go IPO Business Tailwinds
HeartCore CEO Sumitaka Kanno continued: “Recently, the Tokyo Stock Exchange raised the minimum market capitalization requirement for Growth Market companies from ¥4 billion yen after 10 years to ¥10 billion yen after just 5 years. We believe this creates a powerful tailwind for our Go IPO business, as this accelerated timeline will pressure many companies to assess and seek alternative strategies that offer deeper liquidity, greater visibility, and higher valuations such as the Nasdaq and NYSE. Capturing even a small portion of this opportunity has the potential to bring significant long-term value to our growth trajectory.
“In the near term, we will continue to execute our organic growth strategy across Japan and Korea. After a successful Go IPO panel in Seoul last month, we are making significant strides in building out a pipeline with Korean companies that can benefit from our services. We remain committed to growing our Go IPO business to maximize value for our shareholders.”
About HeartCore Enterprises, Inc.
HeartCore is a Tokyo-based IPO consulting services company, guiding Japanese growth companies to achieve successful U.S. exchange listings through its flagship service, Go IPO. HeartCore’s Go IPO
SM
consulting services provide comprehensive consultation support, including pre-IPO consulting, regulatory guidance, financial preparation, and operational readiness to help businesses navigate the complexities of a successful U.S. listing. HeartCore’s goal is to streamline the entire process for Japanese companies to provide a seamless transition into the U.S. public markets. For more details, visit
https://heartcore-enterprises.com/
.
Forward-Looking Statements
All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believed,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.
HeartCore Investor Relations Contact:
Gateway Group, Inc.
John Yi and Steven Shinmachi
[email protected]
(949) 574-3860